Literature DB >> 17070790

Functional impairment of CD4 T cells despite normalization of T cell number in HIV.

Kenneth S Knox1, Richard B Day, Lisa M Kohli, Chadi A Hage, Homer L Twigg.   

Abstract

Using an in vitro model, we demonstrate that when CD4 T cells from HIV infected subjects are enriched from total blood lymphocytes the immune response to antigen is augmented. However, augmentation of this response is confined to HIV infected subjects with relatively preserved CD4 T cell counts. Enriching for CD4 T cells had no effect on antigen responses in patients with low CD4 lymphocyte counts. These findings support the concept that CD4 T cells in late stage HIV have inherent qualitative defects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17070790      PMCID: PMC1821122          DOI: 10.1016/j.cellimm.2006.09.003

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  24 in total

1.  CD4+ T-lymphocyte nadir and the effect of highly active antiretroviral therapy on phenotypic and functional immune restoration in HIV-1 infection.

Authors:  Christoph G Lange; Hernan Valdez; Kathy Medvik; Robert Asaad; Michael M Lederman
Journal:  Clin Immunol       Date:  2002-02       Impact factor: 3.969

2.  Discontinuation of chemoprophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection. HIV Outpatient Study (HOPS) Investigators.

Authors:  B G Yangco; J C Von Bargen; A C Moorman; S D Holmberg
Journal:  Ann Intern Med       Date:  2000-02-01       Impact factor: 25.391

Review 3.  Clinical practice. Management of newly diagnosed HIV infection.

Authors:  Scott M Hammer
Journal:  N Engl J Med       Date:  2005-10-20       Impact factor: 91.245

4.  Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection.

Authors:  Joseph J Mattapallil; Daniel C Douek; Brenna Hill; Yoshiaki Nishimura; Malcolm Martin; Mario Roederer
Journal:  Nature       Date:  2005-04-28       Impact factor: 49.962

5.  Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy.

Authors:  H F Günthard; J K Wong; C A Spina; C Ignacio; S Kwok; C Christopherson; J Hwang; R Haubrich; D Havlir; D D Richman
Journal:  J Infect Dis       Date:  2000-02       Impact factor: 5.226

6.  Lower CD4+ T lymphocyte nadirs may indicate limited immune reconstitution in HIV-1 infected individuals on potent antiretroviral therapy: analysis of immunophenotypic marker results of AACTG 5067.

Authors:  Ronald D'Amico; Yijun Yang; Donna Mildvan; Scott R Evans; Carol T Schnizlein-Bick; Richard Hafner; Nancy Webb; Michael Basar; Robert Zackin; Mark A Jacobson
Journal:  J Clin Immunol       Date:  2005-03       Impact factor: 8.317

7.  Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team.

Authors:  J S Currier; P L Williams; S L Koletar; S E Cohn; R L Murphy; A E Heald; R Hafner; E L Bassily; H M Lederman; C Knirsch; C A Benson; H Valdez; J A Aberg; J A McCutchan
Journal:  Ann Intern Med       Date:  2000-10-03       Impact factor: 25.391

8.  Immune responses to hepatitis C and non-hepatitis C antigens in hepatitis C virus infected and HIV-1 coinfected patients.

Authors:  H Valdez; D Anthony; F Farukhi; A Patki; J Salkowitz; P Heeger; D L Peterson; A B Post; R Asaad; M M Lederman
Journal:  AIDS       Date:  2000-10-20       Impact factor: 4.177

9.  Nadir CD4+ T-cell count and numbers of CD28+ CD4+ T-cells predict functional responses to immunizations in chronic HIV-1 infection.

Authors:  Christoph G Lange; Michael M Lederman; Kathy Medvik; Robert Asaad; Mary Wild; Robert Kalayjian; Hernan Valdez
Journal:  AIDS       Date:  2003-09-26       Impact factor: 4.177

10.  Limited immune restoration after 3 years' suppression of HIV-1 replication in patients with moderately advanced disease.

Authors:  Hernan Valdez; Elizabeth Connick; Kimberly Y Smith; Michael M Lederman; Ronald J Bosch; Ryung S Kim; Marty St Clair; Daniel R Kuritzkes; Harold Kessler; Lawrence Fox; Michelle Blanchard-Vargas; Alan Landay
Journal:  AIDS       Date:  2002-09-27       Impact factor: 4.177

View more
  2 in total

1.  Dissociation of CD154 and cytokine expression patterns in CD38+ CD4+ memory T cells in chronic HIV-1 infection.

Authors:  Enrique Espinosa; Christopher E Ormsby; Gustavo Reyes-Terán; Robert Asaad; Scott F Sieg; Michael M Lederman
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

Review 2.  Impact of antiretroviral therapy on lung immunology and inflammation.

Authors:  Homer L Twigg; Kenneth S Knox
Journal:  Clin Chest Med       Date:  2013-04-08       Impact factor: 2.878

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.